| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/28/2010 | US20100021480 Bioactive substance-blood protein conjugate and stabilization of a bioactive substance using the same |
| 01/28/2010 | US20100021479 Monoclonal Antibodies Against CD30 Lacking in Fucosyl Residues |
| 01/28/2010 | US20100021478 Diagnostic antibody assay |
| 01/28/2010 | US20100021477 DESIGN AND GENERATION OF HUMAN DE NOVO pIX PHAGE DISPLAY LIBRARIES |
| 01/28/2010 | US20100021475 Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| 01/28/2010 | US20100021474 Methods and compositions for targeting hepsin |
| 01/28/2010 | US20100021473 Bispecific Ligands With Binding Specificity to Cell Surface Targets and Methods of Use Therefor |
| 01/28/2010 | US20100021470 Monoclonal antibody production by ebv transformation of b cells |
| 01/28/2010 | US20100021469 Functional role of adrenomedullin (am) and the gene related product (pamp) in human pathology and physiology |
| 01/28/2010 | US20100021468 Novel mhc class ii restricted t cell epitopes from the cancer anitgen, ny eso-1 |
| 01/28/2010 | US20100021467 Method of detecting a cancer cell by aberrant expression of a human k+ ion channel |
| 01/28/2010 | US20100021466 Antagonistic Human LIGHT-Specific Human Monoclonal Antibodies |
| 01/28/2010 | US20100021465 Boris isoforms and methods of detecting and treating disease |
| 01/28/2010 | US20100021462 Gasp1: a follistatin domain containing protein |
| 01/28/2010 | US20100021461 Immunoglobulin formulation and method of preparation thereof |
| 01/28/2010 | US20100021459 Polypeptide constructs for intracellular delivery |
| 01/28/2010 | US20100021457 Detection system and uses therefor |
| 01/28/2010 | US20100021452 Compositions and methods of use for therapeutic antibodies |
| 01/28/2010 | US20100021441 Mhc molecule-binding tumor-associated peptides |
| 01/28/2010 | US20100021384 Use of vhh antibodies for the preparation of peptide vectors for delivering a substance of interest and their applications |
| 01/28/2010 | US20100021379 Chemical Antibodies for Immunotherapy and Imaging |
| 01/28/2010 | CA2733218A1 Neutralizing anti-influenza a virus antibodies and uses thereof |
| 01/28/2010 | CA2731823A1 Detection of prostate cancer using psa glycosylation patterns |
| 01/28/2010 | CA2731797A1 Methods and compositions for discovery of target-specific antibodies using antibody repertoire array (ara) |
| 01/28/2010 | CA2731686A1 Neutralizing anti-influenza a virus antibodies and uses thereof |
| 01/28/2010 | CA2731617A1 Amino acid sequences directed against multitarget scavenger receptors and polypeptides |
| 01/28/2010 | CA2731255A1 Structural variants of antibodies for improved therapeutic characteristics |
| 01/28/2010 | CA2731044A1 Diagnostic antibody assay |
| 01/28/2010 | CA2730804A1 Amyloid .beta. peptide analogues, oligomers thereof, processes for preparing and compositions comprising said analogues or oligomers, and their uses |
| 01/28/2010 | CA2730132A1 Novel angiopoietin derived peptides |
| 01/27/2010 | EP2147679A2 Compositions and methods for modulating blood-brain barrier transport |
| 01/27/2010 | EP2147594A1 Antibody producing non-human mammals |
| 01/27/2010 | EP2146746A2 Prevention and treatment of cerebral amyloid angiopathy |
| 01/27/2010 | EP2146745A2 Novel compounds |
| 01/27/2010 | EP2146727A1 High viscosity macromolecular compositions for treating ocular conditions |
| 01/27/2010 | EP1924605B1 Compositions and methods for diagnosing and treating an inflammation |
| 01/27/2010 | EP1786931B1 Methods and compositions for measuring natriuretic peptides and uses thereof |
| 01/27/2010 | EP1732949B1 Methods for treating bone cancer pain by administering a nerve growth factor antagonist |
| 01/27/2010 | EP1692186B1 Cancer cell targeting gene delivery method |
| 01/27/2010 | EP1234875B1 Novel metalloprotease having aggrecanase activity |
| 01/27/2010 | CN101636413A Monoclonal anti-cxcl13 antibodies |
| 01/27/2010 | CN101636412A Composition of labeled and non-labeled monoclonal antibodies |
| 01/27/2010 | CN101633697A Matched monoclonal antibodies established in accordance with small-molecule carbaryl, and application thereof |
| 01/27/2010 | CN101633696A Monoclonal antibody against human granular enzyme and hybridoma cell strain |
| 01/27/2010 | CN101633695A Preparation method of anti-erbB2 functional antibody based on erbB2 protein extracellular C-terminal functional epitope characteristics |
| 01/27/2010 | CN101633694A Method for preparing polyclonal antibody against mouse nerve growth factor (NGF) and application thereof |
| 01/27/2010 | CN101633693A Monoclonal antibody for resisting GPC3 |
| 01/27/2010 | CN100584948C Procine circoviruses, vaccines and diagnostic reagents |
| 01/27/2010 | CN100584946C Method of humanizing immune system molecules |
| 01/26/2010 | US7651997 Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them |
| 01/26/2010 | US7651854 Administering PC cell-derived growth factor (PCDGF); improves the efficiency of primary hematopoietic cell culture |
| 01/26/2010 | US7651689 Methods of applying ionization radiation for therapy of infections |
| 01/26/2010 | US7651688 Method of modulating the activity of functional immune molecules to CD52 |
| 01/26/2010 | US7651686 Enhancement of immune responses by 4-1bb-binding agents |
| 01/26/2010 | US7651678 Methods to impair hematologic cancer progenitor cells and compounds related thereto |
| 01/26/2010 | CA2642066C Immuno-interactive fragments of the .alpha.c subunit of inhibin |
| 01/26/2010 | CA2499354C Transcription control factor zhx3 |
| 01/26/2010 | CA2421588C Tnf receptor-like molecules and uses thereof |
| 01/26/2010 | CA2371675C Novel uses of antibodies against ache and peptides thereof |
| 01/26/2010 | CA2328803C Anti-procalcitonin antibodies and the preparation and use thereof |
| 01/26/2010 | CA2301499C T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof |
| 01/26/2010 | CA2213500C Use of g class immunoglobulins for the topical treatment of atopic dermatitis |
| 01/26/2010 | CA2188279C Interleukin-15 receptors |
| 01/21/2010 | WO2010009391A1 Compositions monovalent for cd28 binding and methods of use |
| 01/21/2010 | WO2010008075A1 Anti-system asc amino acid transporter 2 (asct2) antibody |
| 01/21/2010 | WO2010008051A1 Anti-human clcp1 antibody and use thereof |
| 01/21/2010 | WO2010007724A1 Peptide capable of binding to epcam |
| 01/21/2010 | WO2010007723A1 Peptide capable of binding to ceramic material |
| 01/21/2010 | WO2010007701A1 Therapeutic agent and test agent for disease with myocardial necrosis |
| 01/21/2010 | WO2010007533A2 Human cytomegalovirus neutralizing antibodies and use thereof |
| 01/21/2010 | WO2010007463A1 Human cytomegalovirus neutralising antibodies and use thereof |
| 01/21/2010 | WO2010007376A2 Compositions monovalent for cd28 binding and methods of use |
| 01/21/2010 | WO2010007144A2 New mutated netrin 4 proteins, fragments thereof and their uses as drugs |
| 01/21/2010 | WO2010007082A1 Compositions and methods of use for therapeutic antibodies |
| 01/21/2010 | WO2010007000A1 Cancerous disease modifying antibodies |
| 01/21/2010 | WO2010006810A1 Recombinant anti-muc1 antibodies |
| 01/21/2010 | WO2010006772A2 Use of cd95 inhibitors for the treatment of inflammatory disorders |
| 01/21/2010 | WO2010006601A1 Pax 5 monoclonal antibody |
| 01/21/2010 | WO2010006508A1 INTEGRIN PEPTIDE, ANTI-CD 18 βA ANTIBODY FOR TREATMENT OF ENDOTOXIN-MEDIATED PRO-INFLAMMATORY RESPONSES AND THE USE |
| 01/21/2010 | WO2010006454A2 Functionalized polypeptides |
| 01/21/2010 | WO2009138484A3 Antibody purification process |
| 01/21/2010 | WO2009130612A3 Prion epitopes and methods of use thereof |
| 01/21/2010 | WO2009016449A8 Antibody purification process by precipitation |
| 01/21/2010 | WO2004056961A9 Methods of identifying compounds that modulate protein activity |
| 01/21/2010 | WO2004041170A9 Compositions and methods for the treatment of immune related diseases |
| 01/21/2010 | WO2004024097A9 Compositions and methods for the treatment of immune related diseases |
| 01/21/2010 | WO2003070899A9 Phospho-specific antibodies to flt3 and uses thereof |
| 01/21/2010 | WO2003061561A9 Epsilon immunoglobulin chain derived peptides for induction of anti-ige antibodies |
| 01/21/2010 | WO2003006609A9 Human cytokine receptor |
| 01/21/2010 | US20100017916 Systems for reducing biomass recalcitrance |
| 01/21/2010 | US20100017898 Therapeutic applications of noncovalent dimerizing antibodies |
| 01/21/2010 | US20100016562 Reducing the immunogenicity of fusion proteins |
| 01/21/2010 | US20100016560 Monoclonal antibody that binds to an epitope of the lipopolysaccharide (LPS) inner core of Neisseria meningitidis for prevention and treatment of neisserial infections |
| 01/21/2010 | US20100016559 Peptide having ability to activate cancer-related gene |
| 01/21/2010 | US20100016558 Cloning and recombinant production of receptor(s) of the activin/tgf-beta superfamily |
| 01/21/2010 | US20100016557 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 01/21/2010 | US20100016556 Method for making humanized antibodies |
| 01/21/2010 | US20100016555 N-Acetylglucosaminyltransferase III Expression in Lower Eukaryotes |
| 01/21/2010 | US20100016424 Production and use of derivatized homoserine lactones |
| 01/21/2010 | US20100016241 Methods and compositions for inhibiting c-met dimerization and activation |